1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 333 F.Supp.2d
  5. 333 F.Supp.2d 265 (2004)
 

IMPAX LABORATORIES, INC. v. AVENTIS PHARMACEUTICALS, INC.

No. CIV.A. 02-581 JJF.

333 F.Supp.2d 265 (2004)

IMPAX LABORATORIES, INC., Plaintiff, v. AVENTIS PHARMACEUTICALS, INC., Defendant.

United States District Court, D. Delaware.

August 30, 2004.

Attorney(s) appearing for the Case

Mary B. Matterer, Esquire and Dale R. Dube, Esquire of Blank Rome LLP, Wilmington, DE, Of Counsel: Charles R. Wolfe, Jr., Esquire and Brain Wm. Higgins, Esquire of Blank Rome LLP, Washington, DC, for Plaintiff Impax Laboratories, Inc.

Jeffrey B. Bove, Esquire of Connolly Bove Lodge & Hutz LLP, Wilmington, DE, Of Counsel: Paul H. Berghoff, Esquire, Curt J. Whitenack, Esquire, James C. Gumina, Esquire, Jeremey E. Noe, Esquire, and Paul S. Tully, Esquire of McDonnell Boehnen Hurlbert & Berghoff, for Defendant Aventis Pharmaceuticals, Inc.

MEMORANDUM OPINION

FARNAN, District Judge.

Impax Laboratories, Inc. ("Impax") filed this action seeking a declaratory judgment that U.S. Patent No. 5,527,814 (the" '814 patent") is invalid, unenforceable, and will not be infringed by Impax's proposed sale of riluzole.

BACKGROUND

I. Procedural

Aventis Pharmaceuticals, Inc. ("Aventis") is a Delaware corporation with its principal place of business in Bridgewater...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases